Interestingly, cagrilintide had a significantly lower rate of vomiting compared to semaglutide when used as a monotherapy
10.1016/j.ghir.2006.03.002 Growth Horm
Primary Goal: Skin Tone vs
Note: TB-500 is far less studied than full-length Thymosin -4, and the following effects are primarily supported for the parent compound: Actin Binding: Sequesters G-actin monomers, regulating cytoskeletal dynamics essential for cell movement (PMID: 22074294 - Thymosin -4) Cell Migration: Enables endothelial cells, keratinocytes, and other repair cells to migrate to injury sites (PMID: 22074294 - Thymosin -4) Anti-inflammatory: Reduces inflammatory cytokines and promotes resolution of inflammation (PMID: 30116499 - Thymosin -4) Matrix Metalloproteinase Regulation: Modulates tissue remodeling enzymes for proper scar formation (PMID: 16607611 - Thymosin -4) Stem Cell Recruitment: May enhance mobilization of stem cells to damaged areas (PMID: 22074294 - Thymosin -4) Complementary Action: BPC-157 establishes the blood supply (angiogenesis) needed for healing, while TB-500 facilitates the cellular migration and tissue remodeling that follows

Cytoskeletal-ECM interactions in mechanotransduction. Nat Rev Mol Cell Biol
PCAC review (July 2026) The FDA stated it intends to consult the Pharmacy Compounding Advisory Committee on July 23, 2026 regarding inclusion of BPC-157 acetate and BPC-157 (free base) on the 503A bulks list